InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Gergen Mark J, Chief Executive Officer. Insider active across 1 companies, notably Poseida Therapeutics, Inc.. Cumulatively, 2 filings have been recorded. The latest transaction was disclosed on 1 February 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
0357,200 shares0
Common Stock
SEC:0001209191-22-006171:0·
0357,200 shares0
Common Stock
SEC:0001209191-22-006171·
2 of 2 declarations
About Gergen Mark J
Mark J. Gergen is the President and CEO of Poseida Therapeutics, Inc. He is responsible for the strategic direction of the company and the management of its operations. His expertise in the biopharmaceutical sector enables him to effectively guide the company towards sustainable growth.
